Company Filing History:
6 out of 8 
1 out of 1,168 
1 out of 1 Years Active: 1996-2015
Title: Genhui Chen: Innovator in Therapeutic Compounds
Introduction
Genhui Chen is a prominent inventor based in Burnaby, Canada. He has made significant contributions to the field of therapeutic compounds, holding a total of 11 patents. His work focuses on developing novel compounds that have the potential to treat various diseases, including cancer and immune disorders.
Latest Patents
Among his latest patents, Chen has developed dithiolopyrrolones with therapeutic activity. This invention provides novel dithiolopyrrolone compounds and their salts, which are useful as treatments for cancer and other proliferative diseases. The invention also includes therapeutic compositions comprising particularly useful types of dithiolopyrrolones, their salts, and methods of using these compounds in treating proliferative diseases such as cancer. Another significant patent involves 1,2-diphenylethene derivatives for the treatment of immune diseases. This invention offers novel 1,2-diphenylethene derivatives and pharmaceutically acceptable salts, along with the process for their production and pharmaceutical compositions. These compounds serve as modulators of T-cells, neutrophils, macrophages, and their associated cytokines, acting as agents for treating immune, inflammatory, and autoimmune diseases.
Career Highlights
Throughout his career, Genhui Chen has worked with various organizations, including Welichem Biotech Inc. His innovative research and development efforts have positioned him as a key figure in the biotechnology sector.
Collaborations
Chen has collaborated with notable professionals in his field, including John M Webster and Jianxiong Li. These collaborations have further enhanced his research and contributed to the advancement of therapeutic innovations.
Conclusion
Genhui Chen's contributions to the field of therapeutic compounds demonstrate his commitment to advancing medical science. His innovative patents and collaborations highlight his role as a leading inventor in the biotechnology industry.